Screening for anal cancer in women with HIV
Part of Cancer, Infections clinical trials.
This study checks for early signs of anal cancer in women with HIV. It could help find problems before they become serious.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with HIV
- You are 45 years old or older
- You receive HIV care at one of these hospitals in Sweden: Karolinska University Hospital in Stockholm, The South Hospital in Stockholm, or Sahlgrenska University Hospital in Gothenburg
- You have never been diagnosed with anal cancer
- You still have your rectum (no rectal amputation)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for early anal cell changes in women who have had high-grade HPV-related problems in the cervix, vagina, or vulva. It may help find concerning changes sooner, using a structured screening exam.
This study compares self-sampling (doing your own swab) to a healthcare professional doing the swab for HPV, a virus that can lead to anal cancer. It is for people with HIV on Réunion Island.
This study tests a self-collected anal swab for detecting HPV (the virus that can cause anal cancer) in people living with HIV. It aims to see if this simple swab is as accurate as a doctor-collected sample, and may help prevent anal cancer.
This trial compares two ways to screen for HPV, a virus linked to anal cancer. People living with HIV will either collect their own sample or have a doctor do it, then switch methods. The goal is to see which is more comfortable and accurate.
This study is looking at ways to screen for anal cancer in people who are at higher risk, such as those with weakened immune systems or a history of abnormal cells in the lower genital tract. It aims to find better methods for early detection.
This trial checks whether anal cancer screening is useful for women age 40 and older who previously had high-grade vulvar pre-cancer (VIN 2/3) or vulvar cancer. It may help find serious problems earlier in people at higher risk.
Hear when a new Anal Canal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.